Endogenous ethanol production in health and disease
- PMID: 38831008
- DOI: 10.1038/s41575-024-00937-w
Endogenous ethanol production in health and disease
Abstract
The gut microbiome exerts metabolic actions on distal tissues and organs outside the intestine, partly through microbial metabolites that diffuse into the circulation. The disruption of gut homeostasis results in changes to microbial metabolites, and more than half of the variance in the plasma metabolome can be explained by the gut microbiome. Ethanol is a major microbial metabolite that is produced in the intestine of nearly all individuals; however, elevated ethanol production is associated with pathological conditions such as metabolic dysfunction-associated steatotic liver disease and auto-brewery syndrome, in which the liver's capacity to metabolize ethanol is surpassed. In this Review, we describe the mechanisms underlying excessive ethanol production in the gut and the role of ethanol catabolism in mediating pathogenic effects of ethanol on the liver and host metabolism. We conclude by discussing approaches to target excessive ethanol production by gut bacteria.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Similar articles
-
The gut-liver axis in liver disease: Pathophysiological basis for therapy.J Hepatol. 2020 Mar;72(3):558-577. doi: 10.1016/j.jhep.2019.10.003. Epub 2019 Oct 14. J Hepatol. 2020. PMID: 31622696 Review.
-
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.Curr Obes Rep. 2019 Sep;8(3):317-332. doi: 10.1007/s13679-019-00352-2. Curr Obes Rep. 2019. PMID: 31175629 Review.
-
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?World J Gastroenterol. 2016 Jan 7;22(1):50-71. doi: 10.3748/wjg.v22.i1.50. World J Gastroenterol. 2016. PMID: 26755860 Free PMC article. Review.
-
Microbiome as a therapeutic target in alcohol-related liver disease.J Hepatol. 2019 Feb;70(2):260-272. doi: 10.1016/j.jhep.2018.10.019. J Hepatol. 2019. PMID: 30658727 Review.
-
Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.Am J Pathol. 2016 Apr;186(4):765-76. doi: 10.1016/j.ajpath.2015.11.017. Am J Pathol. 2016. PMID: 27012191 Free PMC article.
Cited by
-
A study of correlation of the dietary index for gut microbiota with non-alcoholic fatty liver disease based on 2007-2018 National Health and Nutrition Examination Survey.Front Nutr. 2025 Apr 10;12:1573249. doi: 10.3389/fnut.2025.1573249. eCollection 2025. Front Nutr. 2025. PMID: 40276530 Free PMC article.
-
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188. Microorganisms. 2025. PMID: 40572077 Free PMC article. Review.
-
The Intersection of Ultra-Processed Foods, Neuropsychiatric Disorders, and Neurolaw: Implications for Criminal Justice.NeuroSci. 2024 Sep 23;5(3):354-377. doi: 10.3390/neurosci5030028. eCollection 2024 Sep. NeuroSci. 2024. PMID: 39483285 Free PMC article.
-
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease.Gut Microbes. 2025 Dec;17(1):2500099. doi: 10.1080/19490976.2025.2500099. Epub 2025 May 20. Gut Microbes. 2025. PMID: 40394806 Free PMC article. Review.
-
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.Semin Liver Dis. 2025 Mar;45(1):99-113. doi: 10.1055/a-2551-3320. Epub 2025 Mar 29. Semin Liver Dis. 2025. PMID: 40157374 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases